Pregled bibliografske jedinice broj: 427414
Hereditary thrombophilia and hypofibrinolysis in a family with multiple prothrombotic risk factors – a case report
Hereditary thrombophilia and hypofibrinolysis in a family with multiple prothrombotic risk factors – a case report // Journal of Thrombosis and Haemostasis / Mike Greaves and David Lane (ur.).
London : Delhi: Wiley-Blackwell, 2009. str. 775-775 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 427414 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Hereditary thrombophilia and hypofibrinolysis in a family with multiple prothrombotic risk factors – a case report
Autori
Lenicek Krleza, Jasna ; Jakovljevic, Gordana ; Coen Herak, Desiree ; Bronic, Ana ; Stepan Giljevic, Jasminka ; Zadro, Renata ; Nakic, Melita
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Journal of Thrombosis and Haemostasis
/ Mike Greaves and David Lane - London : Delhi : Wiley-Blackwell, 2009, 775-775
Skup
XXII International Congress of Thrombosis and Haemostasis
Mjesto i datum
Boston (MA), Sjedinjene Američke Države, 11.07.2009. - 16.07.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
hereditary thrombophilia; oral contraceptive; adolescent
Sažetak
Thrombophilia, an increased tendency to develop thrombosis, and hypofibrinolysis, a reduced ability to lyse thrombi, may be concomitant hereditary disorders. Having more than one inherited thrombophilia risk factors greatly increases the risk of developing a potentially dangerous blood clot. Reduced plasma fibrinolytic potential is additional risk factor for venous thrombosis. We report a case of 17-year old girl with a family history of multiple deep venous thrombosis, pulmonary embolisms and miscarriages. She was on oral contraceptives when she got left sided ileofemoral thrombosis and bilateral pulmonary embolism. She was anti-coagulated with low molecular weight heparin (LMWH) for 1 week followed by oral anticoagulant Marivarin (warfarin). Complete resolution of thrombosis by Ultrasound Doppler analysis was registered after 12 months. Patient's thrombophilia tests and tests of family members, including genetic polymorphisms of prothrombotic risk factors were done. Multiple mutations including factor V Leiden, prothrombin, methylenetetrahydrofolate reductase (MTHFR) and plasminogen activator inhibitor-1 (PAI-1) were found. The patient is presently asymptomatic on long term follow up of over 3 years with oral anticoagulation, targeting an international normalized ratio (INR) of 2.5.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-3120 - Farmakogenetika u dječjoj onkologiji (Stepan Giljević, Jasminka, MZOS ) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta,
Klinički bolnički centar Zagreb
Profili:
Jasminka Stepan Giljević
(autor)
Renata Zadro
(autor)
Jasna Leniček Krleža
(autor)
Ana Bronić
(autor)
Melita Nakić
(autor)
Gordana Jakovljević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE